|
Sign In to gain access to subscriptions and/or personal tools.
|
Seizures in Alzheimer's Disease: Clinicopathologic Study
Mario F. Mendez, MD, PhD
Department of Neurology, St. Paul-Ramsey Medical Center, and The University of Minnesota, St. Paul, Minnesota.
Peter Catanzaro, BA
Department of Neurology, St. Paul-Ramsey Medical Center, and The University of Minnesota, St. Paul, Minnesota.
Robert C. Doss, BS
Department of Neurology, St. Paul-Ramsey Medical Center, and The University of Minnesota, St. Paul, Minnesota.
Raul Arguello, MD
Department of Neurology, St. Paul-Ramsey Medical Center, and The University of Minnesota, St. Paul, Minnesota.
William H. Frey, II, PhD
Department of Neurology, St. Paul-Ramsey Medical Center, and The University of Minnesota, St. Paul, Minnesota.
New-onset epileptic seizures occur in patients with Alzheimer's disease (AD), but the nature and underlying reasons for these seizures are unclear. We identified new-onset, nonsymptomatic seizures in 77 (17%) of 446 patients with uncomplicated, definite AD on autopsy. Among these seizure patients, 69 had generalized tonic-clonic seizures, and 55 had less than three total seizures. The seizure patients had a younger age of dementia onset than did the remaining AD patients; however, at seizure onset, they averaged 6.8 years into their AD and had advanced dementia. When further compared to 77 AD controls, matched for age of onset and duration, the seizure patients did not differ on medical illnesses, amount of medications, and degree of focal neuropathology. We conclude that a few unprovoked generalized seizures frequently occur late in the course of AD, and that AD patients with a younger age of dementia onset are particularly susceptible to seizures.
Journal of Geriatric Psychiatry and Neurology, Vol. 7, No. 4,
230-233 (1994)
DOI: 10.1177/089198879400700407

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Scarmeas, L. S. Honig, H. Choi, J. Cantero, J. Brandt, D. Blacker, M. Albert, J. C. Amatniek, K. Marder, K. Bell, et al.
Seizures in Alzheimer Disease: Who, When, and How Common?
Arch Neurol,
August 1, 2009;
66(8):
992 - 997.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Palop and L. Mucke
Epilepsy and Cognitive Impairments in Alzheimer Disease
Arch Neurol,
April 1, 2009;
66(4):
435 - 440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Minkeviciene, S. Rheims, M. B. Dobszay, M. Zilberter, J. Hartikainen, L. Fulop, B. Penke, Y. Zilberter, T. Harkany, A. Pitkanen, et al.
Amyloid {beta}-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy
J. Neurosci.,
March 18, 2009;
29(11):
3453 - 3462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. T. Grossberg and A. K. Desai
Management of Alzheimer's Disease
J Gerontol A Biol Sci Med Sci,
April 1, 2003;
58(4):
M331 - M353.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tsolaki, A. Kourtis, D. Divanoglou, M. Bostanzopoulou, and A. Kazis
Monotherapy with Lamotrigine in patients with Alzheimer's disease and seizures
American Journal of Alzheimer's Disease and Other Dementias,
March 1, 2000;
15(2):
74 - 79.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Holschneider and A. F. Leuchter
Clinical Neurophysiology Using Electroencephalography in Geriatric Psychiatry: Neurobiologic Implications and Clinical Utility
J Geriatr Psychiatry Neurol,
October 1, 1999;
12(3):
150 - 164.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Thomas
Seizures and Epilepsy in the Elderly
Arch Intern Med,
March 24, 1997;
157(6):
605 - 617.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Lopera, A. Ardilla, A. Martinez, L. Madrigal, J. C. Arango-Viana, C. A. Lemere, J. C. Arango-Lasprilla, L. Hincapie, M. Arcos-Burgos, J. E. Ossa, et al.
Clinical Features of Early-Onset Alzheimer Disease in a Large Kindred With an E280A Presenilin-1 Mutation
JAMA,
March 12, 1997;
277(10):
793 - 799.
[Abstract]
[PDF]
|
 |
|
|
|